145 related articles for article (PubMed ID: 11217375)
21. Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias.
Frankel AE; McCubrey JA; Miller MS; Delatte S; Ramage J; Kiser M; Kucera GL; Alexander RL; Beran M; Tagge EP; Kreitman RJ; Hogge DE
Leukemia; 2000 Apr; 14(4):576-85. PubMed ID: 10764142
[TBL] [Abstract][Full Text] [Related]
22. Acute-myeloid-leukemia-targeted toxins kill tumor cells by cell-type-specific mechanisms and synergize with TRAIL to allow manipulation of the extent and mechanism of tumor cell death.
Horita H; Frankel AE; Thorburn A
Leukemia; 2008 Mar; 22(3):652-5. PubMed ID: 17882279
[No Abstract] [Full Text] [Related]
23. Diphtheria toxin-interleukin-3 fusion protein (DT(388)IL3) prolongs disease-free survival of leukemic immunocompromised mice.
Black JH; McCubrey JA; Willingham MC; Ramage J; Hogge DE; Frankel AE
Leukemia; 2003 Jan; 17(1):155-9. PubMed ID: 12529673
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxicity of a recombinant diphtheria toxin-granulocyte colony-stimulating factor fusion protein on human leukemic blast cells.
Chadwick DE; Williams DP; Niho Y; Murphy JR; Minden MD
Leuk Lymphoma; 1993 Oct; 11(3-4):249-62. PubMed ID: 7505148
[TBL] [Abstract][Full Text] [Related]
25. Cell-specific modulation of drug resistance in acute myeloid leukemic blasts by diphtheria fusion toxin, DT388-GMCSF.
Frankel AE; Hall PD; McLain C; Safa AR; Tagge EP; Kreitman RJ
Bioconjug Chem; 1998; 9(4):490-6. PubMed ID: 9667951
[TBL] [Abstract][Full Text] [Related]
26. GM-CSF-DFF40: a novel humanized immunotoxin induces apoptosis in acute myeloid leukemia cells.
Mathew M; Zaineb KC; Verma RS
Apoptosis; 2013 Jul; 18(7):882-95. PubMed ID: 23529188
[TBL] [Abstract][Full Text] [Related]
27. Protein engineering of diphtheria toxin. Development of receptor-specific cytotoxic agents for the treatment of human disease.
Murphy JR; Lakkis FG; vanderSpek JC; Anderson P; Strom TB
Targeted Diagn Ther; 1992; 7():365-82. PubMed ID: 1633299
[No Abstract] [Full Text] [Related]
28. Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties.
Hornick JL; Khawli LA; Hu P; Lynch M; Anderson PM; Epstein AL
Blood; 1997 Jun; 89(12):4437-47. PubMed ID: 9192768
[TBL] [Abstract][Full Text] [Related]
29. Fusion cytokine IL-2-GMCSF enhances anticancer immune responses through promoting cell-cell interactions.
Wen Q; Xiong W; He J; Zhang S; Du X; Liu S; Wang J; Zhou M; Ma L
J Transl Med; 2016 Feb; 14():41. PubMed ID: 26850448
[TBL] [Abstract][Full Text] [Related]
30. Design of a recombinant immunotoxin against the human granulocyte-colony stimulating factor receptor.
Babavalian E; Zeinoddini M; Saeedinia AR; Mohammadi R; Xodadadi N
Mol Biol Rep; 2019 Feb; 46(1):1093-1097. PubMed ID: 30565075
[TBL] [Abstract][Full Text] [Related]
31. Recombinant toxins containing human granulocyte-macrophage colony-stimulating factor and either pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells.
Kreitman RJ; Pastan I
Blood; 1997 Jul; 90(1):252-9. PubMed ID: 9207460
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-2 fusion toxin: targeted therapy for cutaneous T cell lymphoma.
Foss FM
Ann N Y Acad Sci; 2001 Sep; 941():166-76. PubMed ID: 11594570
[TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis on K562 cell line and double strand breaks on colon cancer cell line expressing high affinity receptor for granulocyte macrophage-colony stimulating factor (GM-CSF).
Roudkenar MH; Bouzari S; Kuwahara Y; Roushandeh AM; Baba T; Oloomi M; Fukumoto M
Iran Biomed J; 2008 Jan; 12(1):1-6. PubMed ID: 18392089
[TBL] [Abstract][Full Text] [Related]
34. Induction of retinoic acid receptor-alpha by granulocyte macrophage colony-stimulating factor in human myeloid leukemia cell lines.
Shimizu T; Takeda K
Cancer Res; 2000 Aug; 60(16):4544-9. PubMed ID: 10969805
[TBL] [Abstract][Full Text] [Related]
35. Enhanced proliferative activity of PIXY-321, the granulocyte-macrophage colony-stimulating factor and interleukin-3 fusion protein.
Drexler HG; Meyer C
Leuk Lymphoma; 1998 Mar; 29(1-2):119-28. PubMed ID: 9638981
[TBL] [Abstract][Full Text] [Related]
36. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
[TBL] [Abstract][Full Text] [Related]
37. Comparison of four methods for the purification and refolding of human interleukin-2-mouse granulocyte/macrophage colony-stimulating factor fusion protein.
Wen Q; Ma L; Luo W; Zhou MQ; He D; Lin Y; Wu ZQ; He XW; Wang JF; Wang XN
Biotechnol Appl Biochem; 2008 May; 50(Pt 1):41-8. PubMed ID: 17708750
[TBL] [Abstract][Full Text] [Related]
38. Toxicology and pharmacokinetics of DT388-GM-CSF, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor (GM-CSF) in C57BL/6 mice.
Hall PD; Kreitman RJ; Willingham MC; Frankel AE
Toxicol Appl Pharmacol; 1998 May; 150(1):91-7. PubMed ID: 9630457
[TBL] [Abstract][Full Text] [Related]
39. Regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human myeloid leukemia cell line (AML-193) by interleukin-6.
Li Y; Valeriote F; Chen B
Exp Hematol; 1996 Feb; 24(2):94-100. PubMed ID: 8641372
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity of human acute myeloid leukaemia to diphtheria toxin-GM-CSF fusion protein.
Rozemuller H; Rombouts EJ; Touw IP; FitzGerald DJ; Kreitman RJ; Pastan I; Hagenbeek A; Martens AC
Br J Haematol; 1997 Sep; 98(4):952-9. PubMed ID: 9326195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
